PB1023
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PB1023, covering 2012-10-01 to 2015-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM [Phase 2]